Multiple Sourcing Framework Contracts to Speed up the Development of and Access to Innovative Medical Countermeasures: Next-Generation Influenza Vaccines

Published

3 March 2026

Estimated value

€225,000,000

Procedure

neg-w-call

Lots

1

Notice number

00147914-2026

Reference

238003cb-2e50-4526-b994-5b2c972ed895

Official source

Official source

CPV codes

• 73000000Servicios de investigación y desarrollo y servicios de consultoría conexos

Description

This call for tenders aims to speed up the development of next generation influenza vaccines that could be produced in rapidly scalable manufacturing platforms (e.g. nucleic acid approaches and/or production in scalable eukaryotic or bacterial cell culture, in plants or via in vitro transcription), could support products utilising novel administration routes (e.g. nasal, oral or through microneedle patches), confer mucosal immunity, target potentially pandemic influenza A viruses or could be rapidly adapted to pandemic influenza A viruses, which are protective across influenza subtypes or across alpha-influenza viruses, and/or possess intrinsic immunogenicity without the addition of adjuvants. The call will be implemented via a competitive development in phases as foreseen under Pre-Commercial Procurement.

Awards

Frequently asked questions

What is the estimated value of this tender?

The estimated value published by the buyer is €225,000,000.

Who is the buyer of this tender?

The contracting authority is Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency (European Union).